Clinical Trial Update: Multiple Dose Trial of Anti-glycation Agent GLY-230 in Healthy and Diabetic Subjects [Phase 1, Phase 2]

View source ↗

Summary

The document reports the completion of a multiple-dose Phase 1/2 clinical trial of the anti-glycation agent GLY-230 in healthy subjects and individuals with dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• GLY-230

Snippet

Sponsor: Glycadia | Conditions: Diabetic Nephropathy | Phase 1, Phase 2 | Status: COMPLETED